Business ❯Finance ❯Stock Market ❯Market Reactions

Stock Performance

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Genmab will launch a fully financed $97-per-share tender offer with closing targeted for early 2026.

Paramount Skydance Prepares Ellison-Backed Cash Bid for Warner Bros. Discovery

Nasdaq Delists Windtree for $1 Rule Breach as BNB-Treasury Pivot Falters

Two Seas Capital Challenges CoreWeave’s $9 B All-Stock Merger

RBI Grants AU Small Finance Bank In-Principle Approval for Universal Banking

Wall Street Futures Rise on Growing Fed Rate Cut Odds

Kimberly-Clark Tops Q2 Estimates, Raises 2025 Guidance

Global Markets Rally on EU Trade Optimism and Tech Earnings; Indian Stocks Rebound on Bank Profits

GameStop Shares Plunge After Unveiling $1.75 Billion Convertible Note Offering

Balkrishna Industries Shares Plunge 10% Following Analyst Downgrades

Lip-Bu Tan Named Intel CEO as Company Faces Major Challenges

Kroger CEO Resigns Following Ethics Investigation